Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma

Leukemia and Lymphoma

Volumn 45, Issue 12, 2004, Pages 2481-2484

  Depil, Stephane ^a   Leleu, Xavier ^a   Micol, Jean Baptiste ^a   Berthon, Celine ^a   Laï, Jean Luc ^a   Bauters, Francis ^a   Quesnel, Bruno ^a   Facon, Thierry ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Karyotype; Multiple myeloma; Prognosis

Indexed keywords

BETA 2 MICROGLOBULIN; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW DISEASE; CANCER GROWTH; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PLASMACYTOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; SYMPTOMATOLOGY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; FEMALE; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; SURVIVAL RATE; TIME FACTORS;

EID: 11444263136     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190412331283224     Document Type: Article

References (8)

1. Durie, B.G. and Salmon, S.E. (1975) "A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival", Cancer, 36, 842-854.
2. Wisloff, F., Andersen, P., Andersson, T.R., Brandt, E., Eika, C., Fjaestad, K., et al. (1991) "Incidence and follow-up of asymptomatic multiple myeloma. The myeloma project of health region I in Norway. II", European Journal of Haematology, 47, 338-341.
3. Dimopoulos, M.A., Moulopoulos, A., Smith, T., Delasalle, K.B. and Alexanian, R. (1993) "Risk of disease progression in asymptomatic multiple myeloma", American Journal of Medicine, 94, 57-61.
4. Facon, T., Menard, J.F., Michaux, J.L., Euller-Ziegler, L., Bernard, J.F., Grosbois, B., et al. (1995) "Prognostic factors in low tumor mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myelome (GERM)" , American Journal of Hematology, 48, 71-75.
5. Dimopoulos, M.A., Moulopoulos, L.A., Maniatis, A. and Alexanian, R. (2000) "Solitary plasmacytoma of bone and asymptomatic multiple myeloma", Blood, 96, 2037-2044.
6. Tricot, G., Sawyer, J.R., Jagannath, S., Desikan, K.R., Siegel, D., Naucke, S., et al. (1997) "Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants", Journal of Clinical Oncology, 15, 2659-2666.
7. Lai, J.L., Zandecki, M., Mary, J.Y., Bernardi, F., Izydorczyk, V., Flactif, M., et al. (1995) "Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis", Blood, 85, 2490-2497.
8. Lokhorst, H.M., Boom, S.E., Terpstra, W., Roholl, P., Gerdes, J. and Bast, B.J. (1988) "Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67", British Journal of Haematology, 69, 477-481.